acute myeloid leukemia with 11q23 abnormalities
acute myeloid leukemia with 11q23 abnormalities
Explore linked clinical trials. Standard reference: MONDO:00203171 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, acute myeloid leukemia with 11q23 abnormalities, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2025-10-21 | NCT03513484 |